Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details)

v3.21.2
SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details) - $ / shares
Sep. 22, 2021
Sep. 30, 2021
Jun. 17, 2021
Mar. 31, 2021
Class of Stock [Line Items]        
Conversion price per share       $ 0.22
Warrants Issued In Connection With Issuance Of Series B Preferred Stock [Member]        
Class of Stock [Line Items]        
Number of warrants [1]   6,202,861    
Warrants Issued in Connection with Issuance of Preferred Stock [Member]        
Class of Stock [Line Items]        
Warrant exercise price [1]   $ 0.25    
Expiration Date [1]   Oct. 15, 2021    
Warrants Issued in Connection with Issuance of Series B Preferred Stock to Lead Investor [Member]        
Class of Stock [Line Items]        
Number of warrants   475,000    
Warrant exercise price   $ 0.45    
Expiration Date [1]   Jan. 31, 2022    
Warrants Issued in Connection with Issuance of Series B Preferred Stock to Directors [Member]        
Class of Stock [Line Items]        
Number of warrants   65,714    
Warrant exercise price   $ 0.25    
Expiration Date   Oct. 15, 2021    
Warrants Issued To Service Provider [Member]        
Class of Stock [Line Items]        
Number of warrants 750,000 750,000 750,000  
Warrant exercise price   $ 0.22    
Expiration Date Oct. 15, 2021 Oct. 15, 2021    
Series B Preferred Stock [Member]        
Class of Stock [Line Items]        
Warrant expiration date description expiration date of these Series B warrants from September 30, 2021 to October 15, 2021      
Series B Preferred Stock [Member] | Minimum [Member]        
Class of Stock [Line Items]        
Conversion price per share $ 0.35      
Series B Preferred Stock [Member] | Maximum [Member]        
Class of Stock [Line Items]        
Conversion price per share $ 0.25      
[1] On September 22, 2021, the Company’s board of directors approved an extension of the expiration date of these Series B warrants from September 30, 2021 to October 15, 2021, and approved a reduction in the exercise price from $0.35 per share to $0.25 per share.